StonvexLoading…
StonvexStonvexStonvexCore line items from SNDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $238.43M | $234.72M | $383.86M | $447.10M |
Operating Income | $-54.31M | $126.19M | $-294.98M | $-14.69M |
Net Income | $-54.40M | $125.61M | $-295.37M | $-36.03M |
EPS (Diluted) | $-9.27 | $37.92 | $-144.08 | $-17.87 |
Total Assets | $661.27M | $728.55M | $702.83M | $1.27B |
Total Liabilities | $719.43M | $734.11M | $982.10M | Not available |
Cash & Equivalents | $16.91M | $78.69M | $17.89M | $23.98M |
Free Cash Flow OCF − CapEx | $-27.14M | $-39.24M | $-22.43M | $-15.08M |
Shares Outstanding | 6.67M | 6.63M | 2.08M | 2.10M |